AU2007229457A1 - Inhibitors of protein prenyltransferases - Google Patents

Inhibitors of protein prenyltransferases Download PDF

Info

Publication number
AU2007229457A1
AU2007229457A1 AU2007229457A AU2007229457A AU2007229457A1 AU 2007229457 A1 AU2007229457 A1 AU 2007229457A1 AU 2007229457 A AU2007229457 A AU 2007229457A AU 2007229457 A AU2007229457 A AU 2007229457A AU 2007229457 A1 AU2007229457 A1 AU 2007229457A1
Authority
AU
Australia
Prior art keywords
compound
compounds
ggtase
salt
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007229457A
Other languages
English (en)
Inventor
Hannah Fiji
Ohyun Kwon
Fuyuhiko Tamanoi
Masaru Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California, San Diego filed Critical University of California Berkeley
Publication of AU2007229457A1 publication Critical patent/AU2007229457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AU2007229457A 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases Abandoned AU2007229457A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78444306P 2006-03-22 2006-03-22
US60/784,443 2006-03-22
PCT/US2007/007135 WO2007111948A2 (en) 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases

Publications (1)

Publication Number Publication Date
AU2007229457A1 true AU2007229457A1 (en) 2007-10-04

Family

ID=38541651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007229457A Abandoned AU2007229457A1 (en) 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases

Country Status (7)

Country Link
US (1) US8093274B2 (enExample)
EP (1) EP2007383A4 (enExample)
JP (1) JP2009530392A (enExample)
CN (1) CN101431996A (enExample)
AU (1) AU2007229457A1 (enExample)
CA (1) CA2647038A1 (enExample)
WO (1) WO2007111948A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
SG171690A1 (en) 2005-03-22 2011-06-29 Harvard College Treatment of protein degradation disorders
WO2008091349A1 (en) 2006-02-14 2008-07-31 The President And Fellows Of Harvard College Bifunctional histone deacetylase inhibitors
CA2647038A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
WO2007130429A2 (en) * 2006-05-03 2007-11-15 The President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
EP2321264B1 (en) 2008-07-23 2016-05-04 President and Fellows of Harvard College Deacetylase inhibitors and uses thereof
WO2010014054A1 (en) 2008-07-28 2010-02-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
US9125821B2 (en) 2008-07-28 2015-09-08 The Regents Of The University Of California Nanodrug targeting protein geranylgeranylation
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
WO2012097371A2 (en) * 2011-01-14 2012-07-19 The Regents Of The University Of California Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
WO2012116181A2 (en) * 2011-02-24 2012-08-30 The Regents Of The University Of California Small molecules for endothelial cell activation
DK2707031T3 (da) 2011-05-08 2019-10-07 Legochem Biosciences Inc Protein-active agent conjugates and method for preparing the same
WO2013155223A1 (en) * 2012-04-10 2013-10-17 The Regents Of The University Of California Compositions and methods for treating cancer
EP3698797A1 (en) 2017-10-16 2020-08-26 Tsinghua University Mevalonic acid pathway inhibitor and pharmaceutical composition thereof
CN112574041B (zh) * 2020-12-25 2022-10-28 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU2003259717A1 (en) 2002-08-07 2004-02-25 Bristol-Myers Squibb Company Modulators of rabggt and methods of use thereof
JP2006527756A (ja) * 2003-06-19 2006-12-07 ファイザー・プロダクツ・インク Ｎｋ１拮抗薬
CA2647038A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases

Also Published As

Publication number Publication date
WO2007111948A3 (en) 2008-08-07
US8093274B2 (en) 2012-01-10
CA2647038A1 (en) 2007-10-04
WO2007111948A2 (en) 2007-10-04
EP2007383A4 (en) 2010-09-15
US20100063114A1 (en) 2010-03-11
EP2007383A2 (en) 2008-12-31
JP2009530392A (ja) 2009-08-27
CN101431996A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
US8093274B2 (en) Inhibitors of protein prenyltransferases
US8815935B2 (en) Inhibitors of protein prenyltransferases
AU2026202278A1 (en) Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
Kaushik et al. N’-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl) methylene] 2/4-substituted hydrazides: Synthesis and anticonvulsant activity
EP2486005A1 (en) Pyrrolidine gpr40 modulators
NO316117B1 (no) Inhibitorer for farnesyl-protein-transferase, anvendelse av dem og farmasöytiske preparater inneholdende dem
MX2008015638A (es) Acidos fenil aceticos sustituidos como antagonistas de dp-2.
AU2012345863A1 (en) Aryl dihydropyridinones and piperidinones as MGAT2 inhibitors
US20030187027A1 (en) Dioxanes and uses thereof
Mariaule et al. 3-Oxo-hexahydro-1 H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors
TR201906325T4 (tr) Tetrazolon sübstitüeli dihidropiridinon MGAT2 inhibitörleri.
Chamakuri et al. Synthesis of enantiomerically pure 6-substituted-piperazine-2-acetic acid esters as intermediates for library production
EP2280940A1 (en) Novel n-(2-amino-phenyl)-acrylamides
AU2009294668A1 (en) Ortho-aminoanilides for the treatment of cancer
Cateni et al. Synthesis of 4-thiophen-2′-yl-1, 4-dihydropyridines as potentiators of the CFTR chloride channel
EP1219605B1 (en) Urea compounds, process for producing the same and use thereof
US20030064979A1 (en) Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
Astles et al. Diamine containing VLA-4 antagonists
US7662750B2 (en) Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
MXPA00004157A (es) Compuestos 1-aza-2-alquil-6-aril-cicloalcano novedoso, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
Ceusters Eight-membered cyclic amines as novel scaffolds for drug discovery
Liu Novel concepts and methodologies in pseudo natural product chemistry
JP2001172260A (ja) ウレア化合物、その製造法および用途
RU2781452C2 (ru) Соединения и способы усиления деградации белков-мишеней и других полипептидов с помощью e3 убиквитин лигазы
Dilek Studies Toward the Synthesis of Novel MDM2 Inhibitor Candidates

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period